Anavex Life Sciences Corp. (AVXL): Shares Outstanding
86.67M
As of 2025-09-30
92.70M
As of 2026-06-30
+3.6%
3-year compound annual growth
+6.9%
5-year compound annual growth
+10.5%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | 86.67M | +2.2% | 2026-08-28, Balance as of period end |
| 2024-09-30 | 84.80M | +3.3% | 2026-08-28, Balance as of period end |
| 2023-09-30 | 82.07M | +5.3% | 2024-12-23, Balance as of period end |
| 2022-09-30 | 77.94M | +2.7% | 2023-11-27, Balance as of period end |
| 2021-09-30 | 75.92M | +22.4% | 2022-11-28, Balance as of period end |
| 2020-09-30 | 62.05M | +17.8% | 2021-11-24, Balance as of period end |
| 2019-09-30 | 52.65M | +14.6% | 2020-12-28, Balance as of period end |
| 2018-09-30 | 45.93M | +6.0% | 2019-12-16, Balance as of period end |
| 2017-09-30 | 43.33M | +19.8% | 2019-01-25, Balance as of period end |
| 2016-09-30 | 36.17M | +12.9% | 2017-12-11, Balance as of period end |
| 2015-09-30 | 32.04M | +171.6% | 2016-12-14, Balance as of period end |
| 2014-09-30 | 11.80M | n/c | 2015-12-29, Balance as of period end |
| 2013-09-30 | 37.24M | +23.1% | 2014-12-29, Balance as of period end |
| 2012-09-30 | 30.24M | +13.8% | 2013-12-30, Balance as of period end |
| 2011-09-30 | 26.57M | +13.0% | 2012-12-31, Balance as of period end |
| 2010-09-30 | 23.52M | n/a | 2011-12-22, Balance as of period end |